INTRODUCTIONDYSPORT® injections involve a series of small subcutaneous injections designed to weaken certainmuscles that cause skin wrinkling. Weakening of the injected muscles begins to be apparent after 2-3days with the peak effect being reached after 7-14 days. Results can last 3-6 months. The procedurecan be repeated after 3 months; however, injections given at less than 3 month intervals may notproduce a noticeable effect.
ALTERNATIVE TREATMENTSAlternative forms of non-surgical and surgical management for the appearance of wrinkles and lines inthe skin include laser ablation, chemical peels, dermal filler, minimally invasive procedures and face lift.Alternative forms of treatment are all associated with certain risks.
RISKS OF DYSPORT® INJECTIONSEvery procedure involves a certain amount of risk, and it is important that you understand the risksinvolved. An individual’s choice to undergo a procedure is based on the comparison of the risk topotential benefit. Although the majority of patients do no experience these complications, you shoulddiscuss each of them with your provider to make sure you understand the risks, potential complications,and consequences of DYSPORT® injections.-Bleeding It is possible, though unusual, to experience localized bleedingepisode during or after the procedure at the site(s) of injection.Do not take any aspirin or anti-inflammatory medicationsfor ten days prior to your DYSPORT® injectionappointment.-Bruising Following this procedure, it is not uncommon to bruise at theinjection site. Bruising usually resolved in 3-4 days.-Infection Infection is unusual. Should an infection occur, additionaltreatment including antibiotics may be necessary.-Unsatisfactory Results You may be disappointed with the results of the procedure. Theprocedure may result in unacceptable visible deformities, loss offunction and/or loss of sensation.-Allergic reactions In rare cases, local allergies to botulinum toxin A preparations(including DYSPORT®) have been reported. Systemic reactions,which are more serious, may result from any medication orsubstance used during the procedure. Allergic reactions mayrequire additional treatment.-Drooping of the eyelids(Ptosis)This is a rare but transient complication occurring in 1-2% ofpatients. The incidence can be minimized by positioning postinjections. Ptosis usually resolves within several weeks but maytake longer.
-Additional ProceduresShould complications occur, other treatments may be necessary.Even though risks and complications occur infrequently, the risks cited are the ones that are particularly associated with DYSPORT®injections. Although good results are expected, there cannot beany guarantee or warranty expressed or implied with regard to theresults that may be obtained.
DISCLAIMERInformed consent documents are used to communicate information about the proposed treatmentof a disease or condition along with disclosure of risks and alternative forms of treatment(s).The informed consent process attempts to define principles of risk disclosure that should generallymeet the needs of most patients in most circumstances. However, informed consent documentsshould not be considered all inclusive in defining other methods of care and risks encountered.Informed consent documents are not intended to define or serve as the standard of medical care.Standards of medical care are determined on the basis of all of the facts involved in an individualcase and are subject to change as scientific knowledge and technology advance and as practicepatterns evolve.